The global Fluorescence-Guided Surgery Systems market size was valued at USD 84 million in 2022 and is forecast to a readjusted size of USD 351 million by 2029 with a CAGR of 22.6% during review period.
Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.
Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China. In terms of product, Only for Open Surgery is the largest segment, with a share over 86%. In terms of application, Cancer Surgeries is the largest market, with a share over 80%.
North America is the largest consumption place, with a consumption market share nearly 70% in 2019. Following North America, Europe is the second largest consumption place with 1/5 of the consumption market. Market competition is intense. Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ, etc. are the leaders of the industry.
This report is a detailed and comprehensive analysis for global Fluorescence-Guided Surgery Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Fluorescence-Guided Surgery Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Fluorescence-Guided Surgery Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Fluorescence-Guided Surgery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2018-2029
Global Fluorescence-Guided Surgery Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fluorescence-Guided Surgery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fluorescence-Guided Surgery Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stryker
Hamamatsu Photonics
Medtronic
Quest Medical Imaging
Shimadzu
Fluoptics
KARL STORZ
Only for Open Surgery
System for Endoscopy
Cancer Surgeries
Cardiovascular Surgeries
Others
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Strengths:
- Enhanced precision in surgical procedures, improving patient outcomes by aiding in the identification of tumor boundaries.
- Growing demand for minimally invasive surgeries, which aligns with the capabilities of fluorescence-guided systems to reduce recovery times.
Weaknesses:
- High initial cost of fluorescence-guided surgery systems may limit their adoption, especially in resource-limited settings.
- Technical complexity and the need for specialized training could hinder widespread integration into standard surgical practices.
Opportunities:
- Rising prevalence of cancer and other complex diseases presents a significant market opportunity for fluorescence-guided surgical techniques.
- Advances in technology, such as the development of more affordable and user-friendly systems, could expand market reach.
Threats:
- Regulatory hurdles and lengthy approval processes could delay market penetration and adoption of new fluorescence-guided surgery technologies.
- Competitive pressure from alternative imaging and surgical technologies that may offer cost-effective or more efficient solutions.
Political:
- Government policies promoting advanced healthcare technologies may support the adoption of fluorescence-guided surgery systems.
- Political instability or changes in healthcare funding could affect the availability of resources for integrating new surgical technologies.
Economic:
- High costs associated with fluorescence-guided surgery systems could limit access in developing economies, affecting overall market growth.
- Economic recovery and healthcare sector investments are expected to drive the demand for advanced surgical technologies.
Social:
- Increasing awareness among healthcare professionals about the benefits of precision surgeries can foster market adoption.
- The aging population, particularly in developed countries, will likely drive the demand for complex surgeries, increasing the need for advanced surgical tools.
Technological:
- Continuous innovations in fluorescence imaging and minimally invasive surgery techniques will enhance system efficiency and accessibility.
- Integration of artificial intelligence with fluorescence-guided surgery systems may improve diagnostic accuracy and surgical precision.
Environmental:
- Fluorescence-guided systems produce minimal environmental impact, aligning with the growing trend toward eco-friendly medical technologies.
- Limited environmental impact during the use and disposal of these systems may be a key selling point in sustainability-conscious markets.
Legal:
- Stringent medical device regulations and standards for approval may delay the market entry of new systems and innovations.
- Intellectual property rights and patent issues could impact the development and market dynamics of fluorescence-guided surgery systems.
Suppliers:
- Manufacturers of fluorescence-guided surgery systems, including companies specializing in medical imaging and surgical technologies.
- Providers of raw materials, such as specialized imaging components and fluorescent dyes, crucial for system functionality.
Inputs:
- Advanced fluorescence imaging technology and related hardware components used in surgical systems.
- Software solutions that integrate real-time data and imaging for surgical precision.
Processes:
- Development and manufacturing of fluorescence-guided surgery systems, involving research, design, and testing of imaging devices.
- Distribution and training processes for healthcare institutions and surgical teams to adopt and utilize the systems effectively.
Outputs:
- Fluorescence-guided surgery systems delivered to healthcare providers for use in surgeries.
- Training programs and support materials for surgeons and medical staff to optimize system usage in clinical settings.
Customers:
- Hospitals and surgical centers adopting advanced surgical techniques for cancer removal and other complex surgeries.
- Surgeons and healthcare professionals seeking enhanced precision in surgery for improved patient outcomes.
Threat of New Entrants:
- High capital investment and specialized expertise required to develop and manufacture fluorescence-guided surgery systems create significant barriers to entry.
- Stringent regulatory requirements and approval processes for medical devices discourage new competitors from entering the market.
Bargaining Power of Suppliers:
- Limited number of suppliers providing critical components such as imaging technology and fluorescent dyes gives suppliers considerable power.
- Dependence on high-quality, specialized materials for system functionality may increase supplier influence in pricing and availability.
Bargaining Power of Buyers:
- Healthcare providers and hospitals have moderate bargaining power due to the specialized nature of the technology and its necessity for advanced surgeries.
- With growing competition in medical technologies, buyers can leverage alternatives or negotiate better terms for system purchases.
Threat of Substitutes:
- Alternative surgical imaging and navigation systems, such as CT scans and MRIs, present potential substitutes but may lack the precision of fluorescence-guided systems.
- The emergence of AI-driven technologies and robotic-assisted surgery may serve as alternatives to traditional fluorescence-guided systems.
Industry Rivalry:
- Intense competition among established players in the medical device industry, along with rapid technological advancements, intensifies market rivalry.
- Companies are continuously innovating to offer improved functionalities, such as enhanced imaging clarity and integration with AI, fueling competition.
Raw Materials:
- The production of fluorescence-guided surgery systems relies on high-quality materials, such as advanced optical components, lasers, and fluorescent dyes, which are sourced from specialized suppliers.
- Fluctuations in the availability or cost of these critical raw materials can impact the production costs and scalability of these systems.
Technology and R&D:
- Continuous research and development are essential to improving the performance and affordability of fluorescence-guided surgery systems, driving innovation in imaging technologies.
- Collaborations between medical device manufacturers and research institutions facilitate advancements in fluorescence imaging techniques, enhancing system capabilities for precision surgery.
Supplier Relationships:
- Manufacturers rely on a limited number of suppliers for key components like specialized optical lenses and fluorescent agents, creating strong supplier-buyer relationships.
- Dependence on suppliers for high-performance materials requires robust partnerships to ensure timely production and quality control.
Regulatory and Compliance:
- Regulatory approval processes, including certifications from agencies like the FDA and EMA, are crucial for the development and commercialization of these advanced surgical systems.
- Compliance with stringent medical device standards and safety regulations can delay time-to-market but ensures product reliability and safety for clinical use.
Manufacturing:
- Manufacturing processes for fluorescence-guided surgery systems require advanced precision and quality control to ensure the reliability and performance of the imaging technology.
- Scaling production to meet increasing demand while maintaining high standards of quality and regulatory compliance is a key challenge for manufacturers.
Distribution and Logistics:
- Distribution of fluorescence-guided surgery systems involves navigating complex supply chains, including shipping high-value, sensitive equipment to hospitals and surgical centers.
- Timely delivery and ensuring availability in various regions are crucial for market penetration, especially in emerging markets where demand for advanced surgical tools is rising.
Sales and Marketing:
- Effective marketing strategies are critical for educating healthcare providers on the benefits and applications of fluorescence-guided surgery systems, especially in the growing oncology field.
- Building relationships with hospitals, surgical centers, and medical professionals helps drive sales and adoption of these high-cost, high-value technologies.
End Users:
- The primary end users of fluorescence-guided surgery systems include hospitals and surgical centers, particularly those specializing in oncology and complex surgeries.
- Surgeons and healthcare professionals increasingly demand these systems to enhance surgical precision and improve patient outcomes, driving adoption rates.
Customer Support and Training:
- Providing comprehensive training and support for surgical teams is essential to maximize the efficacy and integration of fluorescence-guided systems in clinical settings.
- Ongoing customer support, including maintenance and updates, is critical for ensuring the longevity and reliability of these sophisticated medical devices.
Patient Outcomes:
- The use of fluorescence-guided surgery systems is associated with improved patient outcomes, including reduced recurrence rates and shorter recovery times, which can enhance overall patient satisfaction.
- Positive clinical results and increased safety during surgeries can lead to greater acceptance of these technologies among healthcare providers and patients alike.
Market Feedback:
- Gathering feedback from end users regarding system performance and usability can inform future product development and enhancements, fostering innovation.
- Continuous engagement with healthcare providers helps identify emerging needs and trends, ensuring that fluorescence-guided systems remain relevant and effective in the evolving healthcare landscape.
Chapter 1, to describe Fluorescence-Guided Surgery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fluorescence-Guided Surgery Systems, with price, sales, revenue and global market share of Fluorescence-Guided Surgery Systems from 2018 to 2023.
Chapter 3, the Fluorescence-Guided Surgery Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fluorescence-Guided Surgery Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Fluorescence-Guided Surgery Systems market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescence-Guided Surgery Systems.
Chapter 14 and 15, to describe Fluorescence-Guided Surgery Systems sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Fluorescence-Guided Surgery Systems
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Fluorescence-Guided Surgery Systems Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Only for Open Surgery
1.3.3 System for Endoscopy
1.4 Market Analysis by Application
1.4.1 Overview: Global Fluorescence-Guided Surgery Systems Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer Surgeries
1.4.3 Cardiovascular Surgeries
1.4.4 Others
1.5 Global Fluorescence-Guided Surgery Systems Market Size & Forecast
1.5.1 Global Fluorescence-Guided Surgery Systems Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Fluorescence-Guided Surgery Systems Sales Quantity (2018-2029)
1.5.3 Global Fluorescence-Guided Surgery Systems Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Stryker
2.1.1 Stryker Details
2.1.2 Stryker Major Business
2.1.3 Stryker Fluorescence-Guided Surgery Systems Product and Services
2.1.4 Stryker Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Stryker Recent Developments/Updates
2.2 Hamamatsu Photonics
2.2.1 Hamamatsu Photonics Details
2.2.2 Hamamatsu Photonics Major Business
2.2.3 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product and Services
2.2.4 Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Hamamatsu Photonics Recent Developments/Updates
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Fluorescence-Guided Surgery Systems Product and Services
2.3.4 Medtronic Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Medtronic Recent Developments/Updates
2.4 Quest Medical Imaging
2.4.1 Quest Medical Imaging Details
2.4.2 Quest Medical Imaging Major Business
2.4.3 Quest Medical Imaging Fluorescence-Guided Surgery Systems Product and Services
2.4.4 Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Quest Medical Imaging Recent Developments/Updates
2.5 Shimadzu
2.5.1 Shimadzu Details
2.5.2 Shimadzu Major Business
2.5.3 Shimadzu Fluorescence-Guided Surgery Systems Product and Services
2.5.4 Shimadzu Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Shimadzu Recent Developments/Updates
2.6 Fluoptics
2.6.1 Fluoptics Details
2.6.2 Fluoptics Major Business
2.6.3 Fluoptics Fluorescence-Guided Surgery Systems Product and Services
2.6.4 Fluoptics Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Fluoptics Recent Developments/Updates
2.7 KARL STORZ
2.7.1 KARL STORZ Details
2.7.2 KARL STORZ Major Business
2.7.3 KARL STORZ Fluorescence-Guided Surgery Systems Product and Services
2.7.4 KARL STORZ Fluorescence-Guided Surgery Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 KARL STORZ Recent Developments/Updates
3 Competitive Environment: Fluorescence-Guided Surgery Systems by Manufacturer
3.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Manufacturer (2018-2023)
3.2 Global Fluorescence-Guided Surgery Systems Revenue by Manufacturer (2018-2023)
3.3 Global Fluorescence-Guided Surgery Systems Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Fluorescence-Guided Surgery Systems by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Fluorescence-Guided Surgery Systems Manufacturer Market Share in 2022
3.4.2 Top 6 Fluorescence-Guided Surgery Systems Manufacturer Market Share in 2022
3.5 Fluorescence-Guided Surgery Systems Market: Overall Company Footprint Analysis
3.5.1 Fluorescence-Guided Surgery Systems Market: Region Footprint
3.5.2 Fluorescence-Guided Surgery Systems Market: Company Product Type Footprint
3.5.3 Fluorescence-Guided Surgery Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Fluorescence-Guided Surgery Systems Market Size by Region
4.1.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2029)
4.1.2 Global Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2029)
4.1.3 Global Fluorescence-Guided Surgery Systems Average Price by Region (2018-2029)
4.2 North America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.3 Europe Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.4 Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.5 South America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
4.6 Middle East and Africa Fluorescence-Guided Surgery Systems Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
5.2 Global Fluorescence-Guided Surgery Systems Consumption Value by Type (2018-2029)
5.3 Global Fluorescence-Guided Surgery Systems Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
6.2 Global Fluorescence-Guided Surgery Systems Consumption Value by Application (2018-2029)
6.3 Global Fluorescence-Guided Surgery Systems Average Price by Application (2018-2029)
7 North America
7.1 North America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
7.2 North America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
7.3 North America Fluorescence-Guided Surgery Systems Market Size by Country
7.3.1 North America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
7.3.2 North America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
8.2 Europe Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
8.3 Europe Fluorescence-Guided Surgery Systems Market Size by Country
8.3.1 Europe Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
8.3.2 Europe Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Fluorescence-Guided Surgery Systems Market Size by Region
9.3.1 Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
10.2 South America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
10.3 South America Fluorescence-Guided Surgery Systems Market Size by Country
10.3.1 South America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
10.3.2 South America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Fluorescence-Guided Surgery Systems Market Size by Country
11.3.1 Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Fluorescence-Guided Surgery Systems Market Drivers
12.2 Fluorescence-Guided Surgery Systems Market Restraints
12.3 Fluorescence-Guided Surgery Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Fluorescence-Guided Surgery Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Fluorescence-Guided Surgery Systems
13.3 Fluorescence-Guided Surgery Systems Production Process
13.4 Fluorescence-Guided Surgery Systems Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Fluorescence-Guided Surgery Systems Typical Distributors
14.3 Fluorescence-Guided Surgery Systems Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Fluorescence-Guided Surgery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Fluorescence-Guided Surgery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Stryker Basic Information, Manufacturing Base and Competitors
Table 4. Stryker Major Business
Table 5. Stryker Fluorescence-Guided Surgery Systems Product and Services
Table 6. Stryker Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Stryker Recent Developments/Updates
Table 8. Hamamatsu Photonics Basic Information, Manufacturing Base and Competitors
Table 9. Hamamatsu Photonics Major Business
Table 10. Hamamatsu Photonics Fluorescence-Guided Surgery Systems Product and Services
Table 11. Hamamatsu Photonics Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Hamamatsu Photonics Recent Developments/Updates
Table 13. Medtronic Basic Information, Manufacturing Base and Competitors
Table 14. Medtronic Major Business
Table 15. Medtronic Fluorescence-Guided Surgery Systems Product and Services
Table 16. Medtronic Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Medtronic Recent Developments/Updates
Table 18. Quest Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 19. Quest Medical Imaging Major Business
Table 20. Quest Medical Imaging Fluorescence-Guided Surgery Systems Product and Services
Table 21. Quest Medical Imaging Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Quest Medical Imaging Recent Developments/Updates
Table 23. Shimadzu Basic Information, Manufacturing Base and Competitors
Table 24. Shimadzu Major Business
Table 25. Shimadzu Fluorescence-Guided Surgery Systems Product and Services
Table 26. Shimadzu Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shimadzu Recent Developments/Updates
Table 28. Fluoptics Basic Information, Manufacturing Base and Competitors
Table 29. Fluoptics Major Business
Table 30. Fluoptics Fluorescence-Guided Surgery Systems Product and Services
Table 31. Fluoptics Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Fluoptics Recent Developments/Updates
Table 33. KARL STORZ Basic Information, Manufacturing Base and Competitors
Table 34. KARL STORZ Major Business
Table 35. KARL STORZ Fluorescence-Guided Surgery Systems Product and Services
Table 36. KARL STORZ Fluorescence-Guided Surgery Systems Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. KARL STORZ Recent Developments/Updates
Table 38. Global Fluorescence-Guided Surgery Systems Sales Quantity by Manufacturer (2018-2023) & (Units)
Table 39. Global Fluorescence-Guided Surgery Systems Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Fluorescence-Guided Surgery Systems Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Fluorescence-Guided Surgery Systems, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Fluorescence-Guided Surgery Systems Production Site of Key Manufacturer
Table 43. Fluorescence-Guided Surgery Systems Market: Company Product Type Footprint
Table 44. Fluorescence-Guided Surgery Systems Market: Company Product Application Footprint
Table 45. Fluorescence-Guided Surgery Systems New Market Entrants and Barriers to Market Entry
Table 46. Fluorescence-Guided Surgery Systems Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2023) & (Units)
Table 48. Global Fluorescence-Guided Surgery Systems Sales Quantity by Region (2024-2029) & (Units)
Table 49. Global Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Fluorescence-Guided Surgery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Fluorescence-Guided Surgery Systems Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Fluorescence-Guided Surgery Systems Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 54. Global Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 55. Global Fluorescence-Guided Surgery Systems Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Fluorescence-Guided Surgery Systems Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Fluorescence-Guided Surgery Systems Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Fluorescence-Guided Surgery Systems Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 60. Global Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 61. Global Fluorescence-Guided Surgery Systems Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Fluorescence-Guided Surgery Systems Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Fluorescence-Guided Surgery Systems Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Fluorescence-Guided Surgery Systems Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 66. North America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 67. North America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 68. North America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 69. North America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2023) & (Units)
Table 70. North America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2024-2029) & (Units)
Table 71. North America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Fluorescence-Guided Surgery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 74. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 75. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 76. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 77. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2023) & (Units)
Table 78. Europe Fluorescence-Guided Surgery Systems Sales Quantity by Country (2024-2029) & (Units)
Table 79. Europe Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Fluorescence-Guided Surgery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 82. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 83. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 84. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 85. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2023) & (Units)
Table 86. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity by Region (2024-2029) & (Units)
Table 87. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 90. South America Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 91. South America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 92. South America Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 93. South America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2018-2023) & (Units)
Table 94. South America Fluorescence-Guided Surgery Systems Sales Quantity by Country (2024-2029) & (Units)
Table 95. South America Fluorescence-Guided Surgery Systems Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Fluorescence-Guided Surgery Systems Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Type (2018-2023) & (Units)
Table 98. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Type (2024-2029) & (Units)
Table 99. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Application (2018-2023) & (Units)
Table 100. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Application (2024-2029) & (Units)
Table 101. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Region (2018-2023) & (Units)
Table 102. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity by Region (2024-2029) & (Units)
Table 103. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Fluorescence-Guided Surgery Systems Raw Material
Table 106. Key Manufacturers of Fluorescence-Guided Surgery Systems Raw Materials
Table 107. Fluorescence-Guided Surgery Systems Typical Distributors
Table 108. Fluorescence-Guided Surgery Systems Typical Customers
List of Figures
Figure 1. Fluorescence-Guided Surgery Systems Picture
Figure 2. Global Fluorescence-Guided Surgery Systems Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Type in 2022
Figure 4. Only for Open Surgery Examples
Figure 5. System for Endoscopy Examples
Figure 6. Global Fluorescence-Guided Surgery Systems Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Application in 2022
Figure 8. Cancer Surgeries Examples
Figure 9. Cardiovascular Surgeries Examples
Figure 10. Others Examples
Figure 11. Global Fluorescence-Guided Surgery Systems Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Fluorescence-Guided Surgery Systems Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Fluorescence-Guided Surgery Systems Sales Quantity (2018-2029) & (Units)
Figure 14. Global Fluorescence-Guided Surgery Systems Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Fluorescence-Guided Surgery Systems by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Fluorescence-Guided Surgery Systems Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Fluorescence-Guided Surgery Systems Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Fluorescence-Guided Surgery Systems Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Fluorescence-Guided Surgery Systems Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Fluorescence-Guided Surgery Systems Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Fluorescence-Guided Surgery Systems Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Fluorescence-Guided Surgery Systems Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Fluorescence-Guided Surgery Systems Consumption Value Market Share by Region (2018-2029)
Figure 53. China Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Fluorescence-Guided Surgery Systems Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Fluorescence-Guided Surgery Systems Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Fluorescence-Guided Surgery Systems Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Fluorescence-Guided Surgery Systems Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Fluorescence-Guided Surgery Systems Market Drivers
Figure 74. Fluorescence-Guided Surgery Systems Market Restraints
Figure 75. Fluorescence-Guided Surgery Systems Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Fluorescence-Guided Surgery Systems in 2022
Figure 78. Manufacturing Process Analysis of Fluorescence-Guided Surgery Systems
Figure 79. Fluorescence-Guided Surgery Systems Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
